Pharmaceutical Contract Manufacturing Ma
The global pharmaceutical contract manufacturing market size is projected to grow from $99 billion in 2024 to $156 billion by 2035, representing a CAGR of 4.3%, during the forecast period 2024-2035.
Read More: https://www.rootsanalysis.com/reports/pharmaceutical-contract-manufacturing-market/191.html
In the dynamic landscape of pharmaceutical industry, the dominance of small molecule drugs continues to shape the trajectory of innovation and development. Presently, 90% of the total pharmaceutical drugs are small molecules, despite the fact that biologics have garnered more attention in the recent years due to their capability to treat wide array of disorders. Further, the domain has witnessed a resurgence in the approval of novel small molecule drugs, with over 50 candidates gaining US FDA approval solely in 2020. This trend has driven the business for pharma contract research organization (CRO) services.
0 Total. |
|
